(Reuters) – Israeli drugmaker Teva Pharmaceutical Industries Ltd said on Monday there was sufficient level of participation from U.S. states and local authorities to move forward with its nationwide settlement agreement to resolve opioid-related claims and litigation in the country.
The company had last year agreed to pay up to $4.25 billion, including a supply of the overdose drug naloxone, for the settlement.
(Reporting by Leroy Leo in Bengaluru; Editing by Shinjini Ganguli)
